Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
10/08/2026 13:31
BRIEF-Theravance Biopharma Q2 Operating Income USD -8.277 Million Aug 10 (Reuters) - Theravance Biopharma Q2 EPS USD -0.11.
- Q2 net income USD -5.898 million
- Q2 adjusted net income USD 9.467 million
- Q2 revenue USD 20.731 million vs. IBES estimate USD 21.6 million
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions